GlassScriptPhysician profile
Jennifer Vasquez
NPI 1134890254
$2,850.45
in general payments reported to CMS, 2019-2025
22 companies · $988 in 2025
The $988 reported for 2025 was more than what 84% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,043 · 2023: $521 · 2024: $299 · 2025: $988.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,401 · Travel and Lodging: $361 · Education: $45.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,401.32 |
| Travel and Lodging | $360.85 |
| Education | $45.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $828.81 | 2025 | Percept PC Brainsense |
| Neurocrine Biosciences, INC. | $319.26 | 2022-2023 | Ingrezza, Ongentys |
| Abbvie INC. | $227.79 | 2022-2025 | |
| Biogen, INC. | $220.13 | 2022 | |
| Boston Scientific Corporation | $152.71 | 2023 | Watchman Flx, Watchman Access System |
| Abbott Laboratories | $149.86 | 2023-2025 | Infinity |
| Genzyme Corporation | $149.17 | 2022 | |
| Acadia Pharmaceuticals INC | $136.14 | 2022 | |
| Csl Behring | $125.00 | 2024 | Hizentra |
| Tris Pharma INC | $124.99 | 2023 | Dyanavel Xr, Quillichew Er, Quillivant |
| Eisai INC. | $122.21 | 2024 | |
| Amneal Pharmaceuticals LLC | $60.98 | 2022-2024 | Rytary |
| Tolmar, INC. | $37.65 | 2024-2025 | Eligard |
| Merz Pharmaceuticals, LLC | $36.46 | 2022 | |
| Neurelis, INC. | $28.67 | 2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $20.85 | 2022 | |
| Alexion Pharmaceuticals, INC. | $19.97 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $19.81 | 2022 | |
| Tanabe Pharma America, INC. | $19.45 | 2022 | |
| Corium, LLC | $18.81 | 2023 | Adlarity |
| Pfizer INC. | $18.63 | 2024 | |
| Almatica Pharma LLC | $13.10 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Vasquez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.